Leadership

Kylie Briety

Chairperson

Kylie Brierty is a businesswoman and supporter of medical innovation. She was a principal and director of a large private civil contracting company in WA, served as President of the Civil Contractors Federation (WA) and was a member of the Main Roads Industry Advisory Group. She has been a major shareholder of Selvax since its formation and a supporter of medical research at Curtin University.

Ron Wise

Co-Founder & Director

Ron has a PhD in immunology from the University of Western Australia and undertook postdoctoral research at Stanford University. He is a co-founder and director of Selvax and a major shareholder in the company.

Tony Fitzgerald

Co-Founder & Director

Tony is a co-founder of Selvax. He practiced law before moving into the life sciences sector where he has undertaken numerous technology licensing and collaborative research transactions and company startups.

Paul Watt

Director

Paul has 30 years of experience in biomedical and biotechnology R&D, including 22 years in executive roles. Paul was the Director of Research at the Telethon Kids Institute and led multiple medtech companies.

Delia Nelson BSC PHD

Lead Researcher

Delia is an Associate Professor in the School of Pharmacy and Biomedical Sciences at Curtin University. She has over twenty years research experience in tumour immunology and is a founding fellow, Academy of Science, Royal College of Pathologists of Australasia.